Thank you.
To answer your question, honestly, we've never gone to a developing world country and said, “Why don't you go use CAMR?” But I would say every day of every week we have Gilead people who are in the developing world, whether this be Africa, Latin America, or Southeast Asia, working with ministries of health, talking about how we can meet the needs of their AIDS programs and how we can work to get our products to their patients. So I can specifically say we've met with Thailand in the last couple of weeks. We have people in South Africa today. I'll be going to India next week, meeting with the government there. We have in all cases been able to work out arrangements where they can access our drugs and get the drugs to the patients they feel need to have our drugs, second-line therapies at affordable prices.
Specific to Thailand, we've had a very good relationship with the new government in Thailand. They are very comfortable with Gilead. We've met with them. We've met with their GPO, a generic company there, and their decision was that they're happy accessing the drug from us.
In my mind, if--